Metronidazole Safety in Pregnancy

Introduction to Metronidazole Use

The American College of Obstetricians and Gynecologists recommends metronidazole can be safely used during pregnancy when clinically indicated, with current evidence showing no increased risk of congenital malformations, and the primary consideration being timing of administration based on trimester 1

The Centers for Disease Control and Prevention suggests avoiding oral metronidazole during the first trimester due to historical concerns about potential teratogenicity, though meta-analyses have not demonstrated actual teratogenic effects in humans 2, 3
For bacterial vaginosis in the first trimester, the guideline recommends using clindamycin vaginal cream 2% as the preferred first-line treatment 2
Topical metronidazole formulations are safe throughout all trimesters due to minimal systemic absorption and can be used if needed 3

The recommended regimen for bacterial vaginosis is oral metronidazole 250 mg three times daily for 7 days 2, 3
Alternative regimens include metronidazole 2g orally as a single dose, which is specifically recommended for trichomoniasis 1

Metronidazole is FDA pregnancy category B, indicating no evidence of fetal harm in animal studies 2
Current CDC and ACOG guidelines support metronidazole use during pregnancy for specific indications including trichomoniasis, bacterial vaginosis, and certain gastrointestinal infections 1

Bacterial vaginosis is associated with serious adverse pregnancy outcomes including premature rupture of membranes, preterm labor, preterm birth, and postpartum endometritis 2, 3
Treatment in high-risk pregnant women may reduce the risk of preterm delivery 2, 3

Patients must avoid alcohol during treatment and for 24 hours afterward due to potential disulfiram-like reactions 1
Long-term maternal therapy could theoretically risk neonatal bleeding by inhibiting vitamin K synthesis, and consider treating both mother and neonate with phytomenadione (vitamin K) if prolonged therapy is used 3

If a single 2g oral dose is used during lactation, stop breastfeeding for 12-24 hours after the dose 3
Treatment of sexual partners is essential to prevent reinfection when treating sexually transmitted infections 1
For bacterial vaginosis, routine treatment of male partners is not recommended as it does not influence treatment response or reduce recurrence rates 2